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 Summary
   Increasing interest in precise pre-treatment diagnostics of solid tumors by immunohistochemical 
and molecular techniques requires from the clinicians to search for the methods of large core biopsy 
allowing to obtain specimens with intact morphological structure. Minimum tissue damage, low 
cost of the technique and optimal adjustment to the patient’s needs are the primary concerns. 
Spirotome is a large core biopsy system with (single-use) and without (reusable) vacuum assistance, 
designed for obtaining soft tissue bioptates. Its good performance under clinical conditions, causing 
no damage to the breast tissue nor artifacts of the collected specimen has been proven. The first 
prospective analysis of the group of patients who were proposed to undergo biopsy performed 
with Spirotome or automatic version of the device (Coramate) has been reported. The biopsies were 
performed in 31 cases, and in 30 of them the examination goals were achieved. The system is a safe 
diagnostic device with excellent characteristics. Spirotome/Coramate covers a broad spectrum of 
large core biopsy from Gauge 14 to 8. The system guarantees high specimen quality, the patients’ 
safety and the clinicians’ satisfaction.
 Key words:  breast cancer • large core needle biopsy • mammotome biopsy
 PDF fi le: http://www.polradiol.com/fulltxt.php?ICID=492511 
Otrzymano: 2007.04.10
Zaakceptowano: 2007.05.15
Sygnatura: Pol J Radiol, 2007; 72(3): 43-47
Tumor biopsies performed in order to obtain material for 
histopathological investigations belong to the everyday 
practice in oncology. Clinicians increasingly rely on the 
information coming from biopsy. The objective of this exa-
mination is not only to establish unequivocal diagnosis of 
the tumor, but also to determine the grade of malignancy, 
histological type, hormonal receptors, or other biologi-
cal markers (e.g. Her2-neu). Good clinical practice comes 
to include immunohistochemical or molecular analysis of 
fresh tumor tissue, preceding neoadjuvant (preoperative) 
chemo- and/or radiotherapy. Additionally, tumors impal-
pable on physical examination may become accessible for 
biopsy under the guidance of imaging techniques (USG, 
MMG, MRI). 
The ideal system should allow to obtain large tumor tis-
sue specimens with intact structure (tissue architectonics 
preserved), be easy to operate, inexpensive and applicable 
in multicenter studies. Such biopsy method should be mini-
mally burdensome for the patient. The particular stages of 
the procedure should be visualized so that the view of the 
biopsy needle reaching the lesion would correspond with 
the pathology visible in diagnostic images. 
The new low-invasive and precise breast biopsy method 
has been developed since the 1990’s. The essential part of 
the biopsy system is a needle (4 mm in diameter) containing 
a rotational mechanism. In contrast to conventional fine 
and large core needle biopsies, this method requires only 
one insertion of the needle, because, owing to its rotation, 
it can collect the tissue from any site around the biopsy 
needle. The collected tissue specimens are introduced into 
the needle, and then, with a rotating internal element, pro-
pelled outside. 
Other biopsy systems, based on vacuum aspiration, are not 
widely used, primarily because of high costs and limited 
applicability in multicenter clinical studies. 
The system called Spirotome, tested already on various solid 
tumors, mainly breast cancers, is an alternative solution to 
expensive and complicated vacuum-assisted biopsy systems. 
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Large core needle biopsy is a promising alternative to 
open surgical biopsy because of high sensitivity (97%) and 
consistency (94%) of histopathological re-classification. It 
is, however, necessary to determine the limitation of this 
technique and to develop the optimal criteria for qualifi-
cation of patients. Without precise knowledge in this area, 
diagnoses of benign lesions established on the basis of 
large core needle biopsy in countries with high incidence 
of breast cancer should be treated with considerable 
caution [1]. 
The possibility of accurate determination of breast tumor 
malignancy is an important feature of mammotome biop-
sy. Nevertheless, in 24% who underwent such biopsies, 
the tumors were classified as more advanced after surgi-
cal resection [2]. The underestimation rates for high risk 
tumors and DCIS for 11G vacuum-assisted biopsy were 
16% and 11%, respectively, and were lower than those 
obtained for 14G automatic biopsy – 40% and 15%. Vacuum-
assisted biopsy, in comparison with 14G automatic biopsy, 
may reduce underestimation of for high risk tumors and 
DCIS. A question remains, whether the benefits from use of 
vacuum-assisted biopsy outweigh the extra costs incurred 
by the technique [3].
According to the Center for Health Care Quality 
Monitoring, an ideal biopsy system is „a sensitive and 
specific diagnostic method of impalpable breast lesions, 
characterized by very high accuracy and safety”. 
Other characteristics of so-called ideal biopsy sys-
tem include: 1) unequivocal tumor diagnosis by deter-
mination of malignancy, histological type, hormonal 
receptors, biological markers (immunohistochemical 
and molecular analysis of fresh tumor tissue); 2) preci-
sion – impalpable tumors should be accessible for USG, 
MMG, MRI-guided biopsy; 3) low invasiveness; 4) low 
inconvenience for the patient; 5) easy operation of the 
biopsy system; 6) low cost and 7) easy applicability in 
multicenter studies. Additionally, an ideal biopsy sys-
tem should make it possible to collect tissue specimens: 
8) by single needle insertion; 9) from any location in 
the breast (another organ); 10) with intact structure; 
11) with large volumes – representative for the whole 
tumor. 
One of the systems meeting all the above requirements is 
Spirotome (Figure 1). 
The Spirotome biopsy system has many advantages, inclu-
ding the possibility of: 
–  use for each type of soft tissue, for superficial or deep 
tumors, in the vicinity of the pleural cavity, ribs, bones, 
skin, in breasts of all sizes,
–  intraoperative biopsy of interstitial organs, including very 
soft, e.g. hepatic tissue,
–  obtaining bioptates of Ø 2–3 mm with max. Ø 4 mm needle,
–  multiple biopsies with single needle insertion,
–  sterilization and multiple use as well as single use. 
Biopsy with Spirotome is characterized by:
–  no necessity to be performed in the operation room, with 
the help of assistants and expensive accessory equipment,
–  sufficiency of local anesthesia for the procedure,
–  lower costs than those of other macro-biopsy systems,
–  no “firing” sound distressing for the patient, no cell dis-
persion through shooting,
–  availability of different needle gauges, the largest ones 
(Ø 4 mm) can be used for resection of small lesions,
–  excision of the tissue with a sharp edge without damage 
caused by aspiration inside the needle, as it is the case of 
the other vacuum-assisted systems,
–  visibility under USG how Spirotome progresses and pene-
trates the tumor, which ensures the biopsy of the appro-
priate tissue direct frontal approach. 
The technique of Spirotome biopsy, allowing direct fron-
tal access to the suspicious lesions (Figure 2) is notable. 
Additionally, the bioptate to needle size ratio of 0,75 – bioptate 
3 mm (8 – 10 Gauge), needle thickness 4 mm, is very favorable. 
The first results of clinical studies testing the new biopsy 
system Spirotome have already been published [4]. The aim 
Figure 1.  Four main parts of the Spirotome system.
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of these studies was to develop a system allowing to obtain 
large tissue specimens and large numbers of specimens (up 
to 1000) from one procedure. The following criteria were 
adopted: 
•  the bioptate should be of good quality, with no damage 
due to collection procedure, 
•  the specimen dimensions should be consistent with the 
requirements of immunohistochemical and molecular 
investigations,
•  the system should ensure equally easy collection of nor-
mal and malignant tissues, „in situ” lesions,
•  the system should be relatively inexpensive and easy to 
use in multicenter studies,
•  the method should be „patient-friendly”,
•  it should be possible to record (control) the particular sta-
ges of the biopsy procedure to be sure that the collected 
specimen comes from the lesion observed in diagnostic 
imaging studies. 
The study included 30 patients from different cen-
ters in Belgium and France. The rotational excision 
technique was assessed. The following results were 
obtained: 
•  Tissue specimen
–  diameter 2.6 mm; length 20 mm
–  10 Gauge tisue cylinder
•  Cost per biopsy
–  the materials were generally re-used (one to eight times) 
after thorough cleaning and sterilization
–  cost of 1 device – € 250, the cost of materials with cle-
aning and sterilization is slightly higher
•  The procedure was found not to be associated with “fir-
ing/shot” sound unpleasant for the patients. No distant 
complications of the procedure were noted. In 5 (16%) 
patients subcutaneous hematomas developed. There was 
one case of intra- and post-operative hemorrhage, but 
pressure applied onto the needle insertion site stopped 
the bleeding within 10 min. One patient experienced 
painful symptoms for technical reasons; the procedure 
was discontinued too early and the amount of collected 
tissue was too small.
•  All biopsies can be performed within 20 minutes, and 
80% within 10 minutes
•  Biopsies were performed in 31 cases and in 30 they were 
successful – the diagnostic efficacy amounted to 97%. In 
these cases, reliable histopathological and immunohis-
tochemical assessment of specimens obtained by biopsy 
was possible (Figure 3). 
Clinical assessment of the new biopsy system was the sub-
ject of report published by German authors from the aca-
demic center in Erlangen [5]. The aim of the study was to 
assess the diagnostic value of a new mechanical system 
for breast biopsy. Between 01/2004 and 03/2004, patients 
with BIRADS 5 underwent USG-guided Spirotome (8–10 G) 
biopsy. The patients’ age ranged from 23 to 66 lat. From 
each tumor, 5 tissue cylinders were collected and subject-
ed to morphological, histological and molecular investiga-
tions. The malignancy of 48 out of 50 focal lesions (96%) 
was confirmed and in 2 (4%) cases a benign character was 
determined both in biopsy and in intraoperative specimens. 
In conclusion, the authors state that the new mechanical 
breast biopsy system (Spirotome) is a technically advanced 
and ready-to-use method, especially because of the installed 
steel screw designed foroptimal retrieval of the collected 
biopsy material. The system is also advantageous from the 
economical point of view, because Spirotome is a miltiple-
use device (after sterilization). 
At the begining of the design process concerning the biopsy 
system based on rotational excision technique with spiral 
harvesting needle (Spirotome) it was expected to solve the 
following problems associated with soft tissue biopsy sys-
tems: provide high diagnostic efficacy, without crushing-
related artifacts, reliability, high bioptate/needle diameter 
ratio, low cost, low incidence of complications and a possi-
bility to reach the areas previously inaccessible for the clas-
sic biopsy system. At least two systems of large core needle 
biopsy are currently available on the market – Vacuflash 
and Mammotome, both based on the same vacuum assis-
tance technology. Spirotome is a spiral system without 
 vacuum assistance with diagnostic efficacy so high that 
there is no difference between such type of biopsy and open 
surgical biopsies. 
With bioptate/needle diameter ratio of 0.75, Spirotome 
makes it possible to collect large tissue specimens with 
relatively thin needles (in comparison with Mammotome 
– 0.42 or Vacuflash – 0.70). This property, in combination 
with no „shot” sound distressing for the patient, explains 
the low rate of complications and side effects, making it 
possible to use the technique also in more delicate tissues 
such as the brain, liver or kidney. In hands of a good opera-
tor, the patient gets no unpleasant impressions associated 
with the procedure, because the trephines are small and 
the sound minimal. The examination is well tolerated and 
Figure 2.  With Spirotome, direct frontal access to the suspicious tissue 
is possible.
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safe for the patient, it can be performed in life-threatening 
situations and for so-called difficult locations, such as the 
vicinity of large blood vessels, bones or peripheral nerves. 
Because of its safety and unlimited potential of needle size 
increase, the Spirotome system with larger needle diameter 
could be used for resection of smaller tumors. 
To localize the biopsy site, a clip or dye marker can be left 
in it. As Spirotome „seizes” the tissue prior to excision and 
protects it during the excision, the histological preparation 
undergoes no damage. The absence of artifacts increases 
the reliability of the method and minimizes the interlabora-
tory differences. 
Spirotome is relatively inexpensive – approximately 250 
Euro. It can be used to equip almost all centers (especially 
those treating high numbers of breast cancer cases). The 
cutting instrument can be used many times – after clean-
ing and sterilization, and its efficiency remains unaffected. 
Spirotome is the only system, in which one biopsy set can 
be used many times (up to 8 times with the same efficacy). 
No need of hospitalization reduces the costs increasing the 
applicability of this method. 
Spirotome can be inserted under mammography, USG, CT 
or MRI control. Such technique is generally recommend-
ed because it allows to diagnose the disease at preclini-
cal stage. 
Most radiologists prefer the automatic version of the system. 
In the manual version of USG-guided biopsy collecting sys-
tem, the operator needs both hands and assistance of a tech-
nician or nurse, which is not always possible. An automatic 
version of the biopsy system based on rotational excision 
technique – Coramate (Figure 4) is also available. Automation 
makes material collection even more reliable and  repeatable. 
However, the costs are higher and adjustment to other 
radiological equipment is not so easy. Although Coramate 
was designed to facilitate clinicians’ work, the introduction 
of automatic system function improved neither the sample 
quality, nor the patients’  comfort. 
Another concern is the risk of implantation of tumor cells 
along the biopsy canal. This is possible not only with biop-
sy systems based on rotational excision technique, but 
also with all biopsy methods, including vacuum-assisted 
systems or aspiration fine needle biopsy. Keeping in mind 
the possibility of false overestimation of tumor stage and 
consequent “overtreatment”, care should be taken to reduce 
the risk of tumor cell implantation [6]. The biopsy system 
based on rotational excision technique, collecting tumor 
tissue with intact structure and preserved architectonics, 
addresses these expectations. 
Figure 4.  Automatic version of the biopsy system based on rotational 
excision technique – Coramate.
Figure 3.  Histopathology of bioptates obtained with Spirotome.
A – H&E staining: a breast bioptate without artifacts due 
to structural distortion or crushing. Immunohistochemical 
staining: B – ER/PGR and C – HER2. 
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The unique feature of this system are spiral needles. 
Tissues in the vicinity of bones or large blood vessels can 
be biopsied at the distance of up to 1 mm away from these 
structures. It may not be so important in case of breast 
biopsy, but in case of soft tissue sarcomas located close to 
skeletal structures this feature is of utmost importance. 
The same concerns subcutaneous or intracutaneous lesions. 
In vacuum-assisted systems, all the biopsied area should be 
located below the skin. Biopsy performed with Spirotome 
can be commenced on the skin surface. It is very important 
when the breast is squeezed on the stereotaxic table. In 
postmenopausal women, the breast can be compressed up 
to 3 cm, which is a distance difficult to reach with vacuum-
assisted needles. Similar problems can be encountered in 
the regions below the areola of the nipple. 
Conclusions
•  The biopsy system based on rotational excision technique 
(Spirotome/Coramate) is a safe diagnostic tool with excel-
lent parameters. 
•  Spirotome/Coramate covers a wide range of large core 
needle biopsy, from 14 to 8 Gauge. 
•  The system ensures high bioptate quality and clinicians’ 
satisfaction. 
•  The reusable system is very advantageous from the eco-
nomical point of view, because of the possibility of mul-
tiple use of the materials.
•  This biopsy system can take biopsies in every site in 
the breast, also out of lesions where the other vacuum 
 assisted systems have problems or cannot take biopsies.
